Change - Announcement of Cessation::Cessation of Chief Operating Officer

Issuer & Securities

Issuer/ Manager
SINGAPORE MEDICAL GROUP LIMITED
Securities
SINGAPORE MEDICAL GROUP LTD - SG1Y37945678 - 5OT
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
17-Jun-2022 17:33:02
Status
New
Announcement Sub Title
Cessation of Chief Operating Officer
Announcement Reference
SG220617OTHR286C
Submitted By (Co./ Ind. Name)
Dr Beng Teck Liang
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)

This announcement has been prepared by Singapore Medical Group Limited (the "Company") and its contents have been reviewed by the Company s sponsor, UOB Kay Hian Private Limited (the "Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr Lance Tan, Senior Vice President, at 8 Anthony Road, #01-01, Singapore 229957, telephone (65) 6590 6881.

Additional Details

Name Of Person
Mervyn Lim We Jin
Age
45
Is effective date of cessation known?
Yes
If yes, please provide the date
16/07/2022
Detailed Reason (s) for cessation
To pursue other career opportunities.

Based on its enquiries, the Company s sponsor, UOB Kay Hian Private Limited, is satisfied that, save as disclosed in the announcement, there are no other material reasons for the cessation of Mr. Mervyn Lim We Jin as the Chief Operating Officer of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
22/02/2022
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
0
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Operating Officer ("COO")
Role and responsibilities
The COO provides management to staff and leadership to the organization that aligns with the Group's business plan and overall strategic vision. He is responsible for the day-to-day operations of the Group covering areas such as general clinic operations, marketing, information technology and human resource.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None.
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Directorships
Past (for the last 5 years)
Director of various entities in ResMed (Singapore, Thailand and Taiwan) between July 2016 to November 2021.
Present
None